WooGene B&G Co. Ltd Total Liabilities
WooGene B&G Co. Ltd total liabilities. Based on the latest financial reports, WooGene B&G Co. Ltd (018620) has total liabilities worth ₩50.21 Billion KRW (≈ $34.03 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 018620 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of WooGene B&G Co. Ltd (2011–2024)
Total liabilities of WooGene B&G Co. Ltd from 2011 to 2024. This chart illustrates how WooGene B&G Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of WooGene B&G Co. Ltd to see how much of total assets are deployed in long-term investments.
WooGene B&G Co. Ltd Competitors by Total Liabilities
The table below lists competitors of WooGene B&G Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PB Bankshares Inc
NASDAQ:PBBK
|
USA | $405.08 Million |
|
Athanase Innovation AB
ST:ATIN
|
Sweden | Skr66.61 Million |
|
Ni Hsin Resources Bhd
KLSE:7215
|
Malaysia | RM20.19 Million |
|
Asia Green Energy Public Company Limited
BK:AGE
|
Thailand | ฿4.75 Billion |
|
PP Properti Tbk PT
JK:PPRO
|
Indonesia | Rp8.01 Trillion |
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
UK | GBX3.00 Billion |
|
Aeye Inc
NASDAQ:LIDR
|
USA | $8.26 Million |
|
Chemfab Alkalis Limited
NSE:CHEMFAB
|
India | Rs1.88 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down WooGene B&G Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of WooGene B&G Co. Ltd.
Liquidity & Leverage Metrics
WooGene B&G Co. Ltd Total Liabilities Ratios Explained
WooGene B&G Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WooGene B&G Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WooGene B&G Co. Ltd (2011–2024)
The table below shows the annual total liabilities of WooGene B&G Co. Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩85.08 Billion ≈ $57.66 Million |
+72.74% |
| 2023-12-31 | ₩49.25 Billion ≈ $33.38 Million |
-12.37% |
| 2022-12-31 | ₩56.20 Billion ≈ $38.09 Million |
+23.90% |
| 2021-12-31 | ₩45.36 Billion ≈ $30.74 Million |
-4.93% |
| 2020-12-31 | ₩47.72 Billion ≈ $32.34 Million |
-17.54% |
| 2019-12-31 | ₩57.87 Billion ≈ $39.22 Million |
+72.55% |
| 2018-12-31 | ₩33.54 Billion ≈ $22.73 Million |
-10.80% |
| 2017-12-31 | ₩37.60 Billion ≈ $25.48 Million |
+4.42% |
| 2016-12-31 | ₩36.01 Billion ≈ $24.40 Million |
+77.05% |
| 2015-12-31 | ₩20.34 Billion ≈ $13.78 Million |
+142.38% |
| 2014-12-31 | ₩8.39 Billion ≈ $5.69 Million |
+10.11% |
| 2012-12-31 | ₩7.62 Billion ≈ $5.16 Million |
-5.51% |
| 2011-12-31 | ₩8.06 Billion ≈ $5.47 Million |
-- |
About WooGene B&G Co. Ltd
WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. T… Read more